Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,062 public trials 2,038 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

NCT00074087

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: Karl-Franzens-University Graz Graz, Austria

Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria

Universitaetsklinikum Essen Essen, Germany

Klinikum der Friedrich-Schiller Universitaet Jena Jena, Germany

View Trial Details

Completed

Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma

NCT00566228

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

IMPACT Non Hodgkins Lymphoma (NHL) Study

NCT00903812

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: Not specified

View Trial Details

Completed

Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma

NCT00695409

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

NCT02226861

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants

NCT00001830

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +28 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation

NCT01445132

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Improving Blood Stem Cell Collection and Transplant Procedures

NCT01517035

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, CLL (Chronic Lymphocytic Leukemia), +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Evaluation of Loratadine for G-CSF Induced Bone Pain in Patients With Hematologic Malignancies

NCT02305979

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Phase II Trial Designed to Determine Efficacy and Safety of Bendamustine+Dexamethasone+Thalidomide in R/R MM

NCT01526694

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Division of Hematology and CBMT Bolzano, BZ, Italy

Presidio Ospedaliero di Camposampiero Camposampiero, Padova, Italy

Ospedale S. Martino Belluno, Italy

Ospedale di Castelfranco Veneto Castelfranco Veneto, Italy

View all 19 locations

View Trial Details